Abstract
Introduction

Colorectal cancer represents the second leading cause of cancerrelated deaths due to therapy resistance both in Europe and United States. Drug resistance is thought to cause treatment failure in over 90% of patients with metastatic cancer, while drug resistant micrometastic tumour cells may also reduce the impact of adjuvant chemotherapy treatment
. Drug [6, 7] .
We thus investigated the prognostic significance of drug resistance and stemness markers in CTCs isolated from metastatic colorectal cancer patients treated with L-OHP and 5-FU based regimens.
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